
Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 958 | 958 | 893 | 1033 | 1508 | 1866 |
Fund Return | -4.22% | -4.22% | -10.74% | 1.08% | 8.57% | 6.44% |
Place in category | 700 | 700 | 719 | 231 | 81 | 127 |
% in Category | 77 | 77 | 82 | 37 | 18 | 44 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
AXA Framlington Global Technology a | 964.2M | -4.99 | 7.63 | 17.40 | ||
AXA Framlington Global Technology F | 964.2M | -4.99 | 7.63 | 17.40 | ||
GB00B5LXGG05 | 953.82M | -11.80 | 6.47 | 13.95 | ||
AXA Global Distribution R Acc | 237M | 5.74 | -1.26 | 4.97 | ||
AXA Global Distribution R Inc | 237M | 7.05 | -0.84 | 5.18 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Janus Global Life Sciences Fund U G | 3.54B | 5.15 | 9.71 | 9.90 | ||
Wellington Global Health Care EquiG | 1.7B | 6.70 | 4.03 | 11.14 | ||
Adamant Medtech I GBP | 1.37B | 0.38 | 2.38 | 11.19 | ||
Global Health Care Fund W Acc GBP | 92.24M | 7.87 | 5.51 | 9.11 | ||
Pharmaceuticals Index Trust I Acc | 441.55M | 3.24 | 1.99 | 9.39 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Eli Lilly | US5324571083 | 8.67 | 743.23 | +1.48% | |
Merck&Co | US58933Y1055 | 4.98 | 78.79 | -0.50% | |
Thermo Fisher Scientific | US8835561023 | 4.98 | 444.15 | +1.37% | |
UnitedHealth | US91324P1021 | 4.87 | 587.69 | -1.96% | |
Novo Nordisk B | DK0062498333 | 4.83 | 437.2 | +4.01% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Strong Sell | Strong Sell | Sell |
Technical Indicators | Strong Sell | Strong Sell | Strong Sell |
Summary | Strong Sell | Strong Sell | Strong Sell |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review